Image

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Study of 18F-OP-801 for ALS, AD, MS, PD, and healthy volunteers.

Recruiting
18-80 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study checks the safety of a new tool called 18F-OP-801 for people with different brain diseases like ALS, AD, MS, PD, and healthy volunteers. This tool is used in a type of scan called PET imaging to see if there is inflammation in the brain. Inflammation means the brain may be getting damaged.

Key Points:

  • Study Length: Check with the study team for specific duration and number of visits needed.
  • Participation: Participants must commit to certain lifestyle conditions, like using specific birth control, and regular visits.
  • Risks: Participants cannot have certain medical conditions or recent treatments that may interfere with results.

Eligible participants must be between ages 18-80, have the ability to understand the study rules, and be willing to follow the guidelines. Women must not be pregnant, and all participants must meet health criteria like specific blood tests and being able to lay still during scans. This study helps scientists learn how to better diagnose and treat brain diseases.

Print
Study details
    Amyotrophic Lateral Sclerosis (ALS)
    Parkinson Disease (PD)
    Alzheimer Disease (AD)
    Multiple Sclerosis (MS)

NCT05395624

Ashvattha Therapeutics, Inc.

17 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.